3136 results for «860»
3136 results
State-of-the-art on left main interventions in Latin America
16 May 2024 – From EuroPCR 2024
This session, in collaboration with the Sociedad Latino Americana de Cardiologia Intervencionista (SOLACI), provides insights into the management of left main coronary artery disease in Latin America. Attendees will learn about the revascularization guidelines for left main in the region, the approaches to left main bifurcations...
Trial updates and featured clinical research
16 May 2024 – From EuroPCR 2024
This session showcases a selection of the latest clinical research and trial updates presented at EuroPCR 2024. Attendees will have the opportunity to learn about the findings from studies evaluating the use of OCT-guided PCI for chronic total occlusions, the safety and efficacy of short dual...
The landscape of structural heart interventions
16 May 2024 – From EuroPCR 2024
This session provides a comprehensive overview of the management of structural heart disease, focusing on the differences in procedural approaches for aortic and mitral interventions. Attendees will learn effective strategies to manage procedural complications, as well as how to adapt patient pathways for various structural heart...
Endovascular management for aortic arch aneurysm
16 May 2024 – From EuroPCR 2024
This session showcases a series of complex clinical cases highlighting the endovascular management of aortic arch aneurysms. Attendees will witness scenarios involving hybrid aortic arch debranching with thoracic endovascular aortic repair, the use of fenestrated aortic arch stent grafts, techniques for left subclavian artery preservation, and...
TAVI updates: expanding indications
14 May 2024 – From EuroPCR 2024
This session presents the latest updates and evidence on the expanding indications for transcatheter aortic valve implantation (TAVI). It covers topics such as the impact of unfavorable aortic valve anatomy on TAVI outcomes, sex-specific differences in cardiac damage in aortic stenosis patients undergoing TAVI, the use...
TAVI: how to deal with aortic regurgitation
16 May 2024 – From EuroPCR 2024
This session will explore various cases of TAVI for the management of aortic regurgitation, including patients with pure aortic regurgitation, large annuli, low coronary height, and left ventricular assist devices. Discussions will focus on the transcatheter approach, device selection, and techniques to address these challenging scenarios.
Tackling challenging scenarios of left main PCI
16 May 2024 – From EuroPCR 2024
This session, with the collaboration of the South African Society of Cardiovascular Intervention (SASCI), Bangladesh Society of Cardiovascular Intervention and Indonesian Society of Interventional Cardiology, focuses on overcoming the most challenging issues in complex left main bifurcation stenosis PCI. It includes case discussions on techniques to...
Understanding how to use evidence in clinical practice
14 May 2024 – From EuroPCR 2024
This session focuses on understanding how to apply the latest evidence and clinical guidelines in daily practice for Non-Interventional Cardiologists (NAPs). It covers the influence of patient-reported outcomes on cardiovascular clinical practices, the translation of the 2023 ACS clinical guidelines into NAP's practice, the impact of...
When and how to plug holes in the cathlab
14 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the diagnosis and management of various types of holes and fistulas encountered in the catheterization laboratory. The cases cover a range of scenarios, including large holes in unexpected locations, left ventricle-left atrial appendage fistulas, pulmonary...
Expanding the indications of DCB for complex PCI scenarios
14 May 2024 – From EuroPCR 2024
This session, with the collaboration of various national societies, explores the use of drug-coated balloons (DCBs) in complex PCI scenarios, such as multivessel disease, left main, bifurcations, CTOs, or myocardial infarction. It includes case presentations and discussions on the procedural techniques, patient selection, and lesion preparation...
Fistula aneurysms
14 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the management of fistula aneurysms. The cases cover a range of scenarios, including a rare cause of right ventricular compression, a giant coronary fistula, suspected coronary steal syndrome, and more. Each case is followed by...
When and how to treat the side branch in non-left main bifurcations?
14 May 2024 – From EuroPCR 2024
Explore this video session covering essential techniques for handling bifurcations in coronary interventions. Learn to evaluate side branch significance and the need for a second stent, illustrated through three case studies. Discover main vessel stenting for a large side branch, various approaches like T-stenting, TAP, or...
Hotline: advances in coronary physiology
14 May 2024 – From EuroPCR 2024
This hotline session explores the latest advancements in coronary physiology and their implications for percutaneous coronary intervention (PCI). Topics covered include the influence of pathophysiological patterns of coronary artery disease on the safety and efficacy of PCI, the prognostic value of myocardial ischemic burden in STEMI...
Challenging situations to access the aortic valve - Part 1
15 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that showcase challenging situations in accessing the aortic valve, including cases with severe peripheral arterial disease, tortuous aortic anatomy, and complex comorbidities. The session provides an opportunity to learn from the experiences of experts in navigating these complex scenarios...
Late-breaking trials: TAVI head-to-head
14 May 2024 – From EuroPCR 2024
This session presents the latest findings from several late-breaking trials comparing different transcatheter aortic valve implantation (TAVI) approaches. Topics include outcomes in women with small aortic annuli, the comparison of percutaneous versus surgical treatment for patients with aortic stenosis and coronary disease, the impact of valve...
Different treatment options for PCI in calcified lesions
15 May 2024 – From EuroPCR 2024
This session showcases various treatment options for percutaneous coronary intervention (PCI) in calcified lesions. Attendees will learn about the use of excimer laser atherectomy, intravascular lithotripsy, and other techniques to effectively manage challenging calcified coronary lesions. The session features case presentations and discussions, providing insights into...
Treatment strategies in complex coronary
14 May 2024 – From EuroPCR 2024
This session comprises a selection of complex coronary intervention cases from the EuroPCR 2024 Clinical Case submissions. The cases cover a range of challenging scenarios, including CTO with left ventricular dysfunction and VT storm, subintimal tracking and re-entry, and the decision between native vessel CTO PCI...
NSTEMI in patients in post CABG: a challenging combination
15 May 2024 – From EuroPCR 2024
This session focuses on the management of non-ST-elevation myocardial infarction (NSTEMI) in patients who have previously undergone coronary artery bypass grafting (CABG). Attendees will explore various case presentations and discussions on the challenges and treatment strategies for this complex clinical scenario, including the use of intravascular...
Endovascular treatment for acute chronic heart failure
14 May 2024 – From EuroPCR 2024
This session comprises a selection of complex endovascular cases for the treatment of acute chronic heart failure, including the use of 3D printing and virtual reality to close a pulmonary arteriovenous malformation, closure of a post-septal myectomy ventricular septal defect, and catheter-based treatment of a heart...
Stentless PCI
15 May 2024 – From EuroPCR 2024
This session explores various stentless percutaneous coronary intervention (PCI) strategies, including drug-coated balloon (DCB)-only PCI for chronic total occlusions and de-novo coronary lesions, as well as the use of magnesium resorbable scaffolds. Attendees will learn about the rationale, techniques, and outcomes of these "leave nothing behind"...
